Brief: New Phase 3 Data With Aprocitentan For Patients With Resistant Hypertension Has Been Presented
26/06/2023 19:27
June 26 (Reuters) - Idorsia Ltd IDIA.S :
* NEW PHASE 3 DATA WITH APROCITENTAN FOR PATIENTS WITH
RESISTANT
HYPERTENSION HAS BEEN PRESENTED AT THE EUROPEAN SOCIETY OF
HYPERTENSION ANNUAL MEETING 2023
Source text for Eikon: ID:nGNE4BSsxh
Further company coverage: IDIA.S
((Reuters.Briefs@thomsonreuters.com;))